Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J V Lazarus

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
HIV Medicine|September 3, 2010
Overcoming obstacles to late presentation for HIV infection in EuropeJ V Lazarus, R Jürgens, M Weait, et al.
The International Journal on Drug Policy|July 11, 2017
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responsesJ V Lazarus, K Safreed-Harmon, S R Stumo, et al.
HIV Medicine|March 1, 2018
The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitisD Raben, M Hoekstra, I Sperle, et al.
The International Journal on Drug Policy|May 30, 2020
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, SpainV Saludes, A Antuori, J V Lazarus, et al.
Journal of Internal Medicine|September 1, 2019
We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascadeJ V Lazarus, J M Pericàs, C Picchio, et al.
HIV Medicine|December 6, 2011
Population mobility and the changing epidemics of HIV-2 in PortugalA C Carvalho, E Valadas, L França, et al.
HIV Medicine|May 9, 2018
Scale-up of HIV self-testingS F Jakobsen, D Raben, I Sperle, et al.
Journal of Viral Hepatitis|March 7, 2018
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in EuropeG V Papatheodoridis, A Hatzakis, E Cholongitas, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
HIV Medicine|September 3, 2010
Overcoming obstacles to late presentation for HIV infection in EuropeJ V Lazarus, R Jürgens, M Weait, et al.
The International Journal on Drug Policy|July 11, 2017
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responsesJ V Lazarus, K Safreed-Harmon, S R Stumo, et al.
HIV Medicine|March 1, 2018
The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitisD Raben, M Hoekstra, I Sperle, et al.
The International Journal on Drug Policy|May 30, 2020
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, SpainV Saludes, A Antuori, J V Lazarus, et al.
Journal of Internal Medicine|September 1, 2019
We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascadeJ V Lazarus, J M Pericàs, C Picchio, et al.
HIV Medicine|December 6, 2011
Population mobility and the changing epidemics of HIV-2 in PortugalA C Carvalho, E Valadas, L França, et al.
HIV Medicine|May 9, 2018
Scale-up of HIV self-testingS F Jakobsen, D Raben, I Sperle, et al.
Journal of Viral Hepatitis|March 7, 2018
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in EuropeG V Papatheodoridis, A Hatzakis, E Cholongitas, et al.
Pageof 3